Video
Dr. Sorensen discusses the potential of ultrasound stone treatment
Author(s):
“Ideally…we have a technology that's noninvasive that we can use in the clinic, where they don't require any anesthesia to…break the stones and make them smaller,” says Mathew D. Sorensen, MD, MS, FACS.
Video Player is loading.
In this video, Mathew D. Sorensen, MD, MS, FACS, discusses the findings and further research of the study, “Randomized control trial of ultrasonic propulsion to facilitate clearance of chronic residual fragments,” presented recently at the 2021 American Urological Association Annual Meeting. Sorensen is an associate professor and residency program director of the department of urology at the University of Washington, Seattle, Washington.
Related Videos
Joseph Jacob, MD, on the high CR rate with TAR-200 in NMIBC
John Gore, MD, on radical cystectomy vs bladder-sparing therapy for NMIBC
Jason Hafron, MD, outlines AUA 2025 session on clinical trial recruitment
Study data point to gender disparities in oncology research citations
Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBC
Ekene Enemchukwu, MD, on guideline-associated trends in OAB therapy use
Nitin Yerram, MD, highlights trial of 177Lu-PSMA-617 in localized prostate cancer
Karyn S. Eilber, MD, on patient counseling for onabotA treatment for OAB
Optimizing onabotA for OAB: What are some common misconceptions?
Ian Metzler, MD, on the role for telemedicine, digital health tools in stone disease
Related Content
